These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 27198523)

  • 1. Efficacy and Safety of Induction Chemotherapy in Esophageal Cancer with Airway Involvement.
    Noronha V; Joshi A; Patil VM; Purandare N; Jiwnani S; Ghosh-Laskar S; Nakti D; Bandekar B; Prabhash K
    J Gastrointest Cancer; 2016 Sep; 47(3):294-304. PubMed ID: 27198523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bronchoscopic finding determined outcome after chemoradiotherapy in esophageal cancer patients with airway invasion.
    Yin SY; Chao YK; Tseng CK; Chang HK; Liu YH; Wu YC; Chen TP; Yeh CH
    J Surg Oncol; 2014 Jun; 109(8):808-11. PubMed ID: 24578225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irradiation of carcinoma of the esophagus containing a tracheoesophageal fistula.
    Arlington A; Bohorquez J
    Cancer; 1993 Jun; 71(12):3808-12. PubMed ID: 8508348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multimodal approach for cervical esophageal carcinoma: role of neoadjuvant chemotherapy.
    Suzuki G; Yamazaki H; Ogo E; Abe T; Eto H; Muraki K; Hattori C; Umeno H; Nakashima T; Tanaka T; Nakamura S; Yoshida K
    Anticancer Res; 2014 Apr; 34(4):1989-92. PubMed ID: 24692736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Esophageal carcinoma with airway invasion. Evolution and choices of therapy.
    Altorki NK; Migliore M; Skinner DB
    Chest; 1994 Sep; 106(3):742-5. PubMed ID: 7521814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical relevance of induction triplet chemotherapy for esophageal cancer invading adjacent organs.
    Miyata H; Yamasaki M; Kurokawa Y; Takiguchi S; Nakajima K; Fujiwara Y; Mori M; Doki Y
    J Surg Oncol; 2012 Sep; 106(4):441-7. PubMed ID: 22371189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized phase 2 trial of S1 and oxaliplatin-based chemoradiotherapy with or without induction chemotherapy for esophageal cancer.
    Yoon DH; Jang G; Kim JH; Kim YH; Kim JY; Kim HR; Jung HY; Lee GH; Song HY; Cho KJ; Ryu JS; Kim SB
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):489-96. PubMed ID: 25680595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcome of endoscopic mucosal resection for esophageal squamous cell cancer invading muscularis mucosa and submucosal layer.
    Yoshii T; Ohkawa S; Tamai S; Kameda Y
    Dis Esophagus; 2013 Jul; 26(5):496-502. PubMed ID: 22676622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II study of use of a single cycle of induction chemotherapy and concurrent chemoradiotherapy containing capecitabine/cisplatin followed by surgery for patients with resectable esophageal squamous cell carcinoma: long-term follow-up data.
    Koo DH; Park SI; Kim YH; Kim JH; Jung HY; Lee GH; Choi KD; Song HJ; Song HY; Shin JH; Cho KJ; Yoon DH; Kim SB
    Cancer Chemother Pharmacol; 2012 Mar; 69(3):655-63. PubMed ID: 21968953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of esophageal cancer with airway invasion with induction chemotherapy and concurrent chemoradiotherapy.
    Ku GY; Goodman KA; Rusch VW; Ilson DH
    J Thorac Oncol; 2009 Mar; 4(3):432-4. PubMed ID: 19247092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of induction chemotherapy followed by chemoradiation using intensity-modulated radiation therapy for esophageal adenocarcinoma.
    Gerber N; Ilson DH; Wu AJ; Janjigian YY; Kelsen DP; Zheng J; Zhang Z; Bains MS; Rizk N; Rusch VW; Goodman KA
    Dis Esophagus; 2014 Apr; 27(3):235-41. PubMed ID: 23796070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant tracheoesophageal fistula in patients with esophageal cancer.
    Gschossmann JM; Bonner JA; Foote RL; Shaw EG; Martenson JA; Su J
    Cancer; 1993 Sep; 72(5):1513-21. PubMed ID: 7688653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics and Outcomes of Airway Involvement in Esophageal Cancer.
    Goh KJ; Lee P; Foo AZX; Tan EH; Ong HS; Hsu AAL
    Ann Thorac Surg; 2021 Sep; 112(3):912-920. PubMed ID: 33161017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction chemotherapy followed by surgery for advanced oesophageal cancer.
    Toxopeus EL; Talman S; van der Gaast A; Spaander VM; van Rij CM; Krak NC; Biermann K; Tilanus HW; Mathijssen RH; van Lanschot JJ; Wijnhoven BP
    Eur J Surg Oncol; 2015 Mar; 41(3):323-32. PubMed ID: 25534280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoradiotherapy followed by surgery for squamous cell carcinoma of the thoracic esophagus with clinical evidence of adjacent organ invasion.
    de Manzoni G; Pedrazzani C; Pasini F; Bernini M; Minicozzi AM; Giacopuzzi S; Grandinetti A; Cordiano C
    J Surg Oncol; 2007 Mar; 95(3):261-6. PubMed ID: 17323341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second study on the recurrence risk of isolated esophageal atresia with or without trachea-esophageal fistula among first-degree relatives: no evidence for increased risk of recurrence of EA/TEF or for malformations of the VATER/VACTERL association spectrum.
    Choinitzki V; Zwink N; Bartels E; Baudisch F; Boemers TM; Hölscher A; Turial S; Bachour H; Heydweiller A; Kurz R; Bartmann P; Pauly M; Brokmeier U; Leutner A; Nöthen MM; Schumacher J; Jenetzky E; Reutter H
    Birth Defects Res A Clin Mol Teratol; 2013 Dec; 97(12):786-91. PubMed ID: 24307608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weekly chemotherapy as Induction chemotherapy in locally advanced head and neck cancer for patients ineligible for 3 weekly maximum tolerable dose chemotherapy.
    Patil VM; Noronha V; Joshi A; Muddu VK; Dhumal S; Arya S; Juvekar S; Pai P; Chatturvedi P; Devendra AC; Ghosh S; D'cruz A; Kumar P
    Indian J Cancer; 2014; 51(1):20-4. PubMed ID: 24947091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Esophageal bypass operation prior to definitive chemoradiotherapy in advanced esophageal cancer with tracheobronchial invasion.
    Hihara J; Hamai Y; Emi M; Aoki Y; Taomoto J; Miyata Y; Okada M
    Ann Thorac Surg; 2014 Jan; 97(1):290-5. PubMed ID: 24200399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent chemoradiotherapy with or without surgery for patients with resectable esophageal cancer: An analysis of the National Cancer Data Base.
    Naik KB; Liu Y; Goodman M; Gillespie TW; Pickens A; Force SD; Steuer CE; Owonikoko TK; Ramalingam SS; Higgins K; Beitler JJ; Shin DM; Willingham FF; El-Rayes B; Landry JC; Fernandez FG; Saba NF
    Cancer; 2017 Sep; 123(18):3476-3485. PubMed ID: 28464264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.